查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046688

生物化學品市場－全球產業規模、佔有率、趨勢、機會和預測：按產品類型、最終用途、地區和競爭格局分類，2021-2031年

Bio-Based Chemicals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End-Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物基化學品市場預計將從 2025 年的 1,069.1 億美元大幅成長至 2031 年的 2,062.1 億美元，複合年成長率為 11.57%。

這些源自可再生生物資源（例如農產品、林業殘餘物和有機廢棄物）的工業材料，為傳統的石化燃料衍生化學品提供了永續的替代方案。市場擴張的主要驅動力是各國政府為減少溫室氣體排放而製定的嚴格法規，以及跨國公司為實現淨零碳排放目標而進行的策略轉型。此外，消費者對環保產品的需求不斷成長，也進一步促使製造商將可再生原料納入其供應鏈，以確保長期符合監管要求。

市場概覽
預測期 2027-2031
市場規模：2025年 1069.1億美元
市場規模：2031年 2062.1億美元
複合年成長率：2026-2031年 11.57%
成長最快的細分市場 界面活性劑
最大的市場 北美洲

儘管面臨許多好因素，但由於生產成本高於現有的石化產品，生物基塑膠產業仍面臨許多挑戰。成本差異主要源自於複雜的加工技術和錯綜複雜的供應鏈物流。歐洲生物塑膠協會的報告顯示，到2025年，全球生物基塑膠產能將達到約231萬噸。這表明，儘管該行業正在發展，但仍需克服巨大的經濟挑戰，才能建立起足以匹敵傳統化工行業龐大規模和成本效益的競爭力。

市場促進因素

全球企業向循環經濟模式轉型以及雄心勃勃的碳中和目標，是推動生物基化學品工業化規模生產的強大催化劑。跨國製造商正加速從試點階段過渡到全面商業化生產，旨在確保可再生供應鏈並大幅減少3排放範圍。這一趨勢在對旨在將永續原料轉化為可直接替代化學品的綜合生物煉製廠的大量投資中得到了清晰體現。例如，UPM Biochemicals於2025年12月迎來了一個重要的里程碑，其位於德國萊納的木質生物煉製廠開始商業化生產，年產能達22萬噸。此類設施擴建對於彌合從利基市場應用到大眾市場滲透的差距至關重要，使下游產業能夠在不影響產品性能的前提下，將生物基單乙二醇和可再生功能性填料融入其產品線。

第二個關鍵促進因素是政府為促進綠色化學而製定的嚴格法規和強制性規定，這些法規和規定積極營造有利於創新的經濟環境，並透過直接的財政獎勵來推動創新。政策制定者正透過資助旨在降低生物基技術「綠色溢價」的研究來降低該領域的風險，並創造一個使這些替代能源能夠在經濟上與現有石化燃料衍生產品競爭的環境。例如，美國能源局於2025年1月宣布撥款高達2,300萬美元，用於加速國內可再生化學品和燃料的研發。這些監管方面的利好對於維持市場的長期擴張至關重要。 2025年12月，歐洲生質塑膠協會預測，在政策支持與產業成長策略成功協調的背景下，到2030年，全球生物基塑膠產能將翻倍以上，達到約469萬噸。

市場挑戰

全球生物基化學品市場發展的主要障礙是其生產成本高於現有石化產品。儘管法律規範倡導永續性，但經濟現實是，生物基生產流程仍然是資本密集且技術複雜。與受益於數十年基礎設施最佳化和供應鏈精簡的石化燃料產業不同，生物基產業面臨原料物流分散和加工效率低等挑戰。這些因素共同導致生物基化學品價格溢價顯著，使得下游生產者難以在利潤率通常較低的價格敏感型市場中承擔這些成本。

由於缺乏規模經濟效益，生​​物基塑膠與傳統化學工業相比市場產​​量相對有限，這直接導致了成本差距的擴大。生物基塑膠生產商無法將固定成本分攤到龐大的生產規模上，因此難以實現廣泛應用所需的具有競爭力的價格。該行業微乎其微的市場佔有率進一步凸顯了這一結構性劣勢。根據歐洲生物塑膠協會預測，到2024年，生質塑膠的實際產量僅佔全球塑膠總產量的約0.5%。這項數據表明，儘管生物基塑膠產業持續成長，但仍缺乏與規模龐大、成本效益高的傳統石化產業直接競爭所需的臨界規模。

市場趨勢

生物基化學品市場正經歷一場根本性的變革，精準發酵與合成生物學的融合正在推動這項變革。這使得以往傳統生物方法無法實現的高價值分子能夠被有計劃地生產出來。這一先進趨勢超越了簡單的第一代發酵工藝，利用基因改造微生物將可再生原料轉化為性能更優、選擇性更高、能耗更低的特定化學品。這項技術進步正吸引大量投資，以擴大國內生產能力，超越最初的試點階段。例如，2024年6月，美國能源局，Solugen公司已獲得2.136億美元的貸款擔保，用於建造一座商業生物製造工廠，該工廠將採用這些先進的酶法工藝，從而顯著減少碳排放。

同時，物料平衡產銷監管鏈認證的廣泛應用有效消除了重要的物流障礙，使產業能夠利用現有的石化基礎設施進行生物基生產。這種認證模式允許製造商在複雜的生產網路中結合可再生和化石原料，並透過數學方法將永續成分歸因於特定的最終產品，從而避免了構建完全隔離的供應鏈所帶來的高昂成本。事實證明，這種方法對於向下游合作夥伴提供檢驗的碳減排效果至關重要。例如，BASF在2024年5月報告稱，其物料平衡認證的四氫呋喃產品使客戶能夠比傳統化石替代品減少約25%的二氧化碳排放，證明了該計算模型的商業性可行性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生物衍生化學品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（界面活性劑、油漆和塗料、油墨和染料、合成纖維、化妝品和個人護理用品、黏合劑、潤滑劑、其他）
    • 按應用領域（工業、農業、製藥、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生化產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物衍生化學品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物基化學品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物衍生化學品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物衍生化學品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球生物衍生化學品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BASF SE
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Dow Inc.
  • Archer Daniels Midland Company（ADM）
  • Evonik Industries AG
  • Braskem SA
  • Corbion NV
  • Novozymes A/S
  • Royal DSM NV

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14237

The Global Bio-Based Chemicals Market is projected to expand significantly, growing from USD 106.91 billion in 2025 to USD 206.21 billion by 2031, at a compound annual growth rate of 11.57%. These industrial substances, derived from renewable biological resources like agricultural crops, forestry residues, and organic waste, offer sustainable alternatives to traditional fossil-fuel-based chemicals. This market expansion is primarily fueled by strict government regulations aimed at reducing greenhouse gas emissions and a strategic shift by multinational corporations to achieve net-zero carbon targets. Additionally, increasing consumer demand for environmentally responsible products further compels manufacturers to integrate renewable feedstocks into their supply chains, ensuring long-term regulatory adherence.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 106.91 Billion
Market Size 2031USD 206.21 Billion
CAGR 2026-203111.57%
Fastest Growing SegmentSurfactants
Largest MarketNorth America

Despite these strong catalysts, the sector faces a significant hurdle due to high production costs compared to established petrochemical alternatives. This cost difference largely stems from complex processing technologies and intricate supply chain logistics. As reported by European Bioplastics, global production capacity for bio-based plastics reached approximately 2.31 million tonnes in 2025. This indicates that while the industry is growing, it must still overcome substantial economic challenges to achieve competitive parity with the vast scale and cost efficiency of the traditional chemical sector.

Market Driver

The global corporate transition towards circular economy models and ambitious carbon neutrality targets is a powerful catalyst driving the industrial scaling of bio-based chemical production. Multinational manufacturers are increasingly moving beyond pilot phases to full commercial operations, aiming to secure renewable supply chains and significantly reduce their Scope 3 emissions. This trend is clearly demonstrated by substantial investments in integrated biorefineries, which are designed to convert sustainable feedstocks into direct-replacement chemical alternatives. For example, UPM Biochemicals achieved a major milestone in December 2025 by commencing commercial production at its wood-based biorefinery in Leuna, Germany, boasting an annual capacity of 220,000 tonnes. Such facility expansions are crucial for bridging the gap from niche adoption to mass-market availability, enabling downstream industries to integrate bio-monoethylene glycols and renewable functional fillers into their product lines without compromising performance.

A second key driver is stringent government regulations and mandates promoting green chemistry, which actively foster a supportive economic environment for innovation through direct financial incentives. Policymakers are working to de-risk the sector by funding research aimed at lowering the "green premium" associated with bio-based technologies, thereby making these alternatives economically competitive with fossil-fuel incumbents. Illustrating this commitment, the U.S. Department of Energy announced up to $23 million in funding in January 2025, specifically to accelerate the research and development of domestic renewable chemicals and fuels. These regulatory tailwinds are essential for sustaining long-term market expansion, with European Bioplastics projecting in December 2025 that the global production capacity for bio-based plastics will more than double to approximately 4.69 million tonnes by 2030, reflecting successful alignment between policy support and industrial growth strategies.

Market Challenge

The primary impediment hindering the Global Bio-Based Chemicals Market is the elevated production cost when compared to established petrochemical alternatives. While regulatory frameworks advocate for sustainability, the economic reality reveals that bio-based manufacturing processes remain capital-intensive and technologically complex. Unlike the fossil-fuel sector, which benefits from decades of optimized infrastructure and streamlined supply chains, the bio-based industry contends with fragmented feedstock logistics and lower processing efficiencies. These factors collectively impose a significant price premium on bio-based chemicals, making it challenging for downstream manufacturers to absorb these costs in price-sensitive markets where profit margins are often narrow.

This cost disparity is further aggravated by the absence of economies of scale, a direct consequence of the market's relatively limited production volume compared to the traditional chemical industry. Without the ability to distribute fixed costs across massive output levels, bio-based producers struggle to achieve the competitive pricing necessary for widespread adoption. This structural disadvantage is underscored by the sector's marginal market presence; according to European Bioplastics, in 2024, the actual production of bioplastics constituted only about 0.5 percent of global plastic production. This statistic highlights that despite ongoing growth, the industry lacks the critical mass needed to directly compete with the vast, cost-efficient operations of the conventional petrochemical sector.

Market Trends

The market for bio-based chemicals is undergoing a fundamental transformation due to the integration of precision fermentation and synthetic biology, enabling the programmed production of high-value molecules previously unattainable through conventional biological methods. This advanced trend utilizes genetically engineered microorganisms to convert renewable feedstocks into specific, performance-enhanced chemicals with high selectivity and reduced energy consumption, moving beyond simpler first-generation fermentation processes. This technological advancement is attracting substantial investment to scale domestic manufacturing capabilities beyond initial pilot phases. For instance, the U.S. Department of Energy announced in June 2024 that Solugen received a conditional commitment for a $213.6 million loan guarantee to construct a commercial bio-manufacturing facility that will employ these advanced enzyme-based processes to significantly reduce carbon emissions.

Simultaneously, the widespread adoption of mass balance chain-of-custody certification is effectively resolving critical logistical hurdles, allowing the industry to leverage existing petrochemical infrastructure for bio-based production. This certification model permits manufacturers to combine renewable and fossil feedstocks within complex production networks while mathematically attributing the sustainable content to specific final products, thereby circumventing the prohibitive costs associated with building entirely segregated supply chains. This approach is proving essential for delivering verifiable carbon reductions to downstream partners. As an example, BASF reported in May 2024 that the certification of its mass-balanced tetrahydrofuran enabled a customer to achieve an approximate 25 percent reduction in CO2 emissions compared to conventional fossil-based alternatives, validating the commercial viability of this accounting model.

Key Market Players

  • BASF SE
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Dow Inc.
  • Archer Daniels Midland Company (ADM)
  • Evonik Industries AG
  • Braskem S.A.
  • Corbion N.V.
  • Novozymes A/S
  • Royal DSM N.V.

Report Scope

In this report, the Global Bio-Based Chemicals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Based Chemicals Market, By Product Type

  • Surfactants
  • Paints & Coatings
  • Inks and Dyes
  • Man-made Fibres
  • Cosmetics & Personal Care
  • Adhesives
  • Lubricants
  • Others

Bio-Based Chemicals Market, By End-Use

  • Industrial
  • Agricultural
  • Pharmaceutical
  • Others

Bio-Based Chemicals Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Based Chemicals Market.

Available Customizations:

Global Bio-Based Chemicals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-Based Chemicals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Surfactants, Paints & Coatings, Inks and Dyes, Man-made Fibres, Cosmetics & Personal Care, Adhesives, Lubricants, Others)
    • 5.2.2. By End-Use (Industrial, Agricultural, Pharmaceutical, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Bio-Based Chemicals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bio-Based Chemicals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End-Use
    • 6.3.2. Canada Bio-Based Chemicals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End-Use
    • 6.3.3. Mexico Bio-Based Chemicals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End-Use

7. Europe Bio-Based Chemicals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bio-Based Chemicals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End-Use
    • 7.3.2. France Bio-Based Chemicals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End-Use
    • 7.3.3. United Kingdom Bio-Based Chemicals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End-Use
    • 7.3.4. Italy Bio-Based Chemicals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End-Use
    • 7.3.5. Spain Bio-Based Chemicals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End-Use

8. Asia Pacific Bio-Based Chemicals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bio-Based Chemicals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End-Use
    • 8.3.2. India Bio-Based Chemicals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End-Use
    • 8.3.3. Japan Bio-Based Chemicals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End-Use
    • 8.3.4. South Korea Bio-Based Chemicals Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End-Use
    • 8.3.5. Australia Bio-Based Chemicals Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End-Use

9. Middle East & Africa Bio-Based Chemicals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bio-Based Chemicals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End-Use
    • 9.3.2. UAE Bio-Based Chemicals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End-Use
    • 9.3.3. South Africa Bio-Based Chemicals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End-Use

10. South America Bio-Based Chemicals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End-Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-Based Chemicals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End-Use
    • 10.3.2. Colombia Bio-Based Chemicals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End-Use
    • 10.3.3. Argentina Bio-Based Chemicals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bio-Based Chemicals Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cargill, Incorporated
  • 15.3. DuPont de Nemours, Inc.
  • 15.4. Dow Inc.
  • 15.5. Archer Daniels Midland Company (ADM)
  • 15.6. Evonik Industries AG
  • 15.7. Braskem S.A.
  • 15.8. Corbion N.V.
  • 15.9. Novozymes A/S
  • 15.10. Royal DSM N.V.

16. Strategic Recommendations

17. About Us & Disclaimer